Company: ABBV
Filing Date: 2025-02-14
Form Type: 10-K
Source: 0001551152-25-000020
Chunk: 168

Company: AbbVie Inc.
Filing Date: 2025-02-14
Form: 10-K
Item: Item 2
Chunk 168
---
ITEM 2. PROPERTIES

AbbVie's corporate offices are located at 1 North Waukegan Road, North Chicago, Illinois 60064-6400. As of December 31, 2024, AbbVie owns or leases approximately 602 facilities worldwide, containing an aggregate of approximately 19.7 million square feet of floor space dedicated to production, distribution and administration. AbbVie's significant manufacturing facilities are in the following locations:

United States Outside the United StatesAbbott Park, Illinois* Campoverde di Aprilia, ItalyBarceloneta, Puerto Rico Clonshaugh, IrelandBranchburg, New Jersey*Cork, IrelandCincinnati, OhioLa Aurora, Costa RicaDublin, California*Ludwigshafen, GermanyIrvine, CaliforniaPringy, FranceNorth Chicago, IllinoisSingapore*Waco, TexasSligo, IrelandWorcester, Massachusetts* Westport, Ireland*Wyandotte, Michigan*

_______________________________________________________________________________

*    Leased property.

AbbVie believes its facilities are suitable and provide adequate production capacity for its current and projected operations. There are no material encumbrances on AbbVie's owned properties.

AbbVie distributes products through a network of central and regional distribution centers, with its central distribution centers located in the U.S. and Europe. AbbVie also has research and development facilities in the United States located at: Abbott Park, Illinois; Branchburg, New Jersey; Cambridge, Massachusetts; Irvine, California; Madison, New Jersey; North Chicago, Illinois; Pleasanton, California; South San Francisco, California; Waltham, Massachusetts, and Worcester, Massachusetts. Outside the United States, AbbVie's principal research and development facilities are located in Ludwigshafen, Germany.